Type 1 Diabetic and Hypertensive Retinopathy: Case Presentation and Review of Literature
DOI:
https://doi.org/10.17140/DROJ-1-118Keywords:
Type 1 diabetes mellitus; Diabetic retinopathy, Hypertensive retinopathy; Non-proliferative diabetic retinopathy, Flame hemorrhage; Dot hemorrhage; IRMA, Digital imaging; OCT; OCTA Angiography, Telemedicine; Blood Pressure; Blood Glucose; HypertensionAbstract
Background: Type 1 Diabetes (T1D) Mellitus is a complex, chronic illness that affects half a million children under the age of 15 years. Complications associated with diabetic retinopathy can be prevented with continued self-management of Blood Glucose (BG) and Blood Pressure (BP) into adulthood. In this case, we present a 20-year-old man with a 15 year history of T1D who loses control of his BG and BP for 2 years. Methods: Blood pressure, visual acuity and intraocular pressures were measured at the time of visit. Non-mydriatic retinal imaging was performed using a Canon CR-2 Plus AF with a resolution of 18 megapixel. A Spectral Domain (SD)-OCT provided a 5 micron resolution of the posterior pole including the macula/fovea. Optical Coherence Tomography Angiography (OCTA)
(Optovue, Inc., Fremont, CA, USA) captured 6*6 mm angiograms centered on macula. Team- ViewerTM was used to perform remote tele-presence tele-ophthalmology. Results: Color Fundus Photo (CFP) of the subject in 2013 showed few hemorrhages with virtually no signs of retinopathy although his BP, last Glycated hemoglobin (HbA1c) and BG were uncontrolled (130/91 mm Hg, 13+, 421 mg/dL, respectively). Two years later, after 15 years of diabetes, his BP, last HbA1c, and BG are still uncontrolled (142/62 mm Hg, 13.5%,
and 319 mg/dL, respectively). CFP and tele-consultation confirms severe Non-proliferative diabetic retinopathy (NPDR), after 131 days since last annual eye examination, with 259 retinal hemorrhages and 12 Intraretinal microvascular abnormalities (IRMAs) in his left eye. OCT was normal, but OCTA identified areas of retinal telangiectasia and micro-aneurysm formation. 21
days following NPDR diagnosis, he reduced BP to 122/78 mm Hg, HbA1c to 10%, and BG to 115 mg/dL. CFP showed 80 fewer hemorrhages and 10 IRMAs. 57 days following NPDR diagnosis, subject had BP of 107/72 mm Hg and BG of 124 mg/dL. CFP showed 180 fewer hemorrhages and 13 IRMAs. Conclusions: As BG and BP were decreased and maintained within normal levels, the subject
benefited from reduction in retinopathy findings. This case identifies the role non-mydriatic retinal imaging, OCT, and OCTA may play in the assessment and follow-up of patients with long duration type 1 diabetes. Tele-ophthalmology can be an important tool in the follow-up and second opinion of screened patients. An emphasis on BP monitoring can play an important role in the better management of patients with type I diabetes. Close monitoring and maintenance of BP below 130/80, fasting BG under 120 mg/dL, and HbA1c<10% can help reduce NPDR microvascular complications and save vision.
References
Klandorf H, Stark SW. Diabetes mellitus. Magill’s Medical Guide (Online Edition), 2014.
International Diabetes Federation. Diabetes Atlas. 5th ed. IDF. Brussels, Belgium, 2011.
Patterson C, Guariguata L, Dahlquist G, Soltesz G, Ogle G, Silink M. Diabetes in the young: a global view and worldwide estimates of numbers of children with type 1 diabetes. Diabe-tes Research and Clinical Practice. 2014; 103: 161-175. doi: 10.1016/j.diabres.2013.11.005
Guariguata L. Estimating the worldwide burden of type 1 dia-betes. Diabetes Voice. 2011; 56 (2): 6-8.
Latreille M, Herrmanns K, Renwick N, et al. miR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker development. Journal of Molecular Medi-cine. 2015; 93(10): 1159-1169. doi: 10.1007/s00109-015-1296-9
Bhatt S, Gupta MK, Khamaisi M, et al. Preserved DNA dam-age checkpoint pathway protects against complications in long-standing type 1 diabetes. Cell Metabolism. 2015; 22(2): 239- 252. doi: 10.1016/j.cmet.2015.07.015
Watkins PJ. Retinopathy. ABC of Diabetes. 2003; 326: 924- 926.
American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2014; 37(Suppl. 1): S14-S80.
Klein R, Klein BK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy: III. Prevalence and risk of diabetic retinopathy when age at diag-nosis is 30 or more years. Arch Ophthalmol. 1984; 102(4): 527- 532. doi: 10.1001/archopht.1984.01040030405011
Frank RN. Diabetic retinopathy and systemic factors. Middle East African Journal of Ophthalmology. 2015; 22(2): 151-156.
Sun JK, Keenan HA. Protection from retinopathy and other complications in patients with type 1 diabetes of extreme dura-tion. Diabetes Car. 2011. 34: 968-974. doi: 10.2337/dc10-1675
Arauz-Pacheco C, Parrott MA, Raskin P. The treatment of hypertension in adult patients with diabetes. Diabetes Care. 2002; 25(1): 134-147. doi: 10.2337/diacare.25.1.134
Rosner B, Prineas RJ, Loggie JMH, Daniels SR. Blood pres-sure nomograms for children and adolescents, by height, sex, and age in the United States. The Journal of Pediatrics. 199; 123: 871-886.
Aronson D. Hyperglycemia and pathobiology of diabetic complications. Advanced Cardiology. 2008; 45: 1-16. doi: 10.1159/0000115118
Tiedeman JS, Kirk SE, Srinivas S, Beach JM. Retinal oxy-gen consumption during hyperglycemia in patients with diabetes without retinopathy. Ophthalmology. 1998; 105(1): 31-36.
Taylor RH, Jones HS, Dodson PM, et al. Diabetic eye dis-ease: a natural history study. Eye. 1997; 11: 547-553. doi: 10.1038/eye.1997.141
Mendez N, Kommana S, Wu L, Padgaonkar P, Szirth B, Khouri AS. Use of high resolution digital retinal imaging in the early detection of retinopathy in type 1 diabetes. Diabetes Re-search Open Journal. 2015; 1(4): 79-83. doi: 10.17140/DROJ-1-114
Gangaputra S, Lovato JF, Hubbard L, et al. Comparison of standardized clinical classification with fundus photograph grading for the assessment of diabetic retinopathy and diabetic macular edema severity. Retina. 2013; 33(7): 1393-1399. doi: 10.1097/IAE.0b013e318286c952
Akram MU, Khalid S, Khan SA. Identification and classifi-cation of microanerysms for early detection of diabetic retinopa-thy. Pattern Recognition. 2013; 46: 107-116. doi: 10.1016/j.pat-cog.2012.07.002
Ling R, James B. White-centered retinal haemorrhages. Postgraduate Med J. 1998; 74(876): 581-582.
Cuspidi C, Meani S, Valerio C, et al. Prevalence and cor-relates of advanced retinopathy in a large selected hypertensive population: the evaluation of target organ damage hypertension study. Blood Pressure. 2005; 14: 25-30.
Yu T, Mitchell P, Frcophth F, Berry G, Li W, Wang JJ. Reti-nopathy in older person without diabetes and its relationship to hypertension. Archives of Ophthalmology. 1998; 116: 83-89. doi: 10.1001/archopht.116.1.83
Shechtman DL, Kabat AG. The many faces of a retinal hem-orrhage: the pathophysiology of the retinal vascular system and the classification of a retinal hemorrhage aids in diagnosis. Op-tometric Management. 2008; 43(1): 33-39.
Yanoff M, Duker JS. Ophthalmology. 3rd ed. St. Louis, Mo: Mosby Inc; 2008.
Garner A. Histopathology of diabetic retinopathy in man. Eye. 1993; 7: 250-253.
Gangnon RE, Davis MD, Hubbard LD, et al. Early Treat-ment Diabetic Retinopathy Study Research Group. A severity scale for diabetic macular edema developed from ETDRS data. Invest Ophthalmol Vis Sci. 2008; 49(11): 5041-5047.
Wu L, Fernandez-Loaiza P, Sauma J, Hernandez-Bogantes E, Masis M. Classification of diabetic retinopathy and diabetic macular edema. World J Diabetes. 2013; 4(6): 290-294. doi: 10.4239/wjd.v4.i6.290
Fullerton B, Jeitler K, Seitz M, Horvath K, Berghold A, Siebenhofer A. Intervensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews. 2014; 2: 1469-1493.
Erden S, Bicakci E. Hypertensive retinopathy: incidence, risk factors, and comorbidites. Clinical and Experimental Hyperten-sion. 2012; 34: 397-401. doi: 10.3109/10641963.2012.663028
Fowler MJ. Microvascular and macrovascular complications of diabetes. Clinical Diabetes. 2008; 26: 77-82. doi: 10.2337/ diaclin.26.2.77
Rassam SMB, Patel V, Kohner EM. The effect of experi-mental hypertension on retinal vascular autoregulation in hu-mans: a mechanism for the progression of diabetic retinopathy. Experimental Physiology. 1995; 80: 53-68. doi: 10.1113/exp-physiol.1995.sp003834
Do DV, Wang X, Vedula SS, et. al. Blood pressure control for diabetic retinopathy. Cochrane Database Syst Rev. 2015; 1: CD006127. doi: 10.1002/14651858.CD006127 .pub2
Chatterjee S, Chattopadhya S, Hope-Ross M, Lip PL. Hyper-tension and the eye: changing perspectives. Journal of Human Hypertension. 2002; 16: 667-675. doi: 10.1038/sj.jhh.1001472
Bock KD. Regression of retinal vascular changes by anti-hypertensive therapy. Hypertension. 1984; 6: 158-162.
Hypertension in Diabetes Study (HDS). Prevalence of hy-pertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens. 1993; 11: 309-317.
Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International. 2002; 61: 1086-1097. doi: 10.1046/j.1523- 1755.2002.00213.x
UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS. 38. BMJ. 1998; 317: 703-713. doi: 10.1136/bmj.317.7160.703
Hansson L, Zanchetti A, Carruthers SG, et al. Effects of in-tensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998; 351: 1755- 1762. doi: 10.1016/S0140-6736(98)04311-6
National Institutes of Health. Landmark ACCORD trial finds intensive blood pressure and combination lipid therapies do not reduce combined cardiovascular events in adults with diabetes [article online]. Available from http://www.nih.gov/news/health/ mar2010/nhlbi-15.htm 2010; Accessed February, 2010.
Bryden KS, Peveler RC, Stein A, Neil A, Mayou RA, Dunger DB. Clinical and psychological course of diabetes from adoles-cence to young adulthood: a longitudinal cohort study. Diabetes Care. 2000; 24(9): 1536-1540.
Gallego PH, Craig ME, Hing S, Donaghue KC. Role of blood pressure in development of early retinopathy in adolescents with type 1 diabetes: prospective cohort study. BMJ. 2008; 337: a918. doi: 10.1136/bmj.a918
Taylor RH, Jones HS, Dodson PM, et al. Diabetic eye dis-ease: a natural history study. Eye. 1997; 11: 547-553.
Fong DS, Aiello L, Gardner TW, et al. Retinopathy in diabe-tes. Diabetes Care. 2004; 27(Suppl 1): s84-s87.
Long AN, Dagogo-Jack S. The comorbidities of diabetes and hypertension: mechanisms and approach to target organ protec-tion. J Clin Hypertens. 2013; 4: 244-251.
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Diabetes Research (DR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.